Immunology and Microbiology
Adaptive Immune System
5%
Antiviral Activity
5%
CD81
6%
Cell Culture
6%
Cell Line
5%
Coculture
5%
Cytotoxic T-Cell
14%
Dengue Virus
7%
Dynamics
5%
Epitope
7%
Glycoprotein
7%
Hepatitis B
17%
Hepatitis B Virus
49%
Hepatitis C
49%
Hepatitis C Virus
100%
Hepatitis Delta Virus
14%
Hepatitis E Virus
14%
Host Factor
5%
Host Range
11%
Host Tropism
6%
Human Immunodeficiency Virus
6%
Human Immunodeficiency Virus 1
11%
Humanized Mouse
50%
Immune Response
18%
Immune System
13%
Immunity
6%
Infectious Agent
14%
interferon
16%
Interferon Type III
8%
Life Cycle
9%
Liver Cell
6%
Liver Cell Culture
5%
Memory T Cell
7%
Mouse Model
26%
Neutralizing Antibody
21%
Peptides
6%
Plasmodium
8%
Plasmodium falciparum
5%
Rhesus Monkey
5%
RNA Virus
6%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
T Cell
20%
Transgenic Mouse
6%
Viral Disease
20%
Viral Entry
19%
Viral Pathogenesis
6%
Viral Replication
16%
Virus
32%
Virus Vaccine
11%
Yellow Fever Virus
7%
Keyphrases
Broadly Neutralizing Antibodies
19%
CD8+ T Cells
9%
CD81
7%
Chimpanzee
10%
Chronic Infection
9%
Covalently Closed Circular DNA
10%
Cross-species Transmission
7%
Entry Factors
7%
H2-M3
7%
Hepatitis B
8%
Hepatitis B Virus
46%
Hepatitis B Virus Infection
11%
Hepatitis C
17%
Hepatitis C Vaccine
11%
Hepatitis C Virus
96%
Hepatitis C Virus Entry
14%
Hepatitis C Virus Infection
47%
Hepatitis delta Virus
16%
Hepatitis E Virus
16%
Hepatocellular Carcinoma
8%
Hepatocytes
9%
Hepatotropic Viruses
8%
Host Tropism
7%
Human Immune System
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
9%
Humanized
9%
Humanized Mice
45%
Humanized Mouse Model
17%
Immune Response
8%
Interferon-α (IFN-α)
8%
Liver
11%
Liver Disease
8%
Malaria
7%
Mouse Model
12%
Neutralizing Antibodies
8%
Occludin
9%
Primary Hepatocytes
8%
Severe Liver Injury
7%
Small Animal Model
21%
T Cell Response
9%
Type I Interferon
7%
Type III Interferon
8%
Vaccine Candidate
8%
Viral
7%
Viral Pathogenesis
9%
Virus
26%
Virus Life Cycle
7%
Virus Replication
10%
Virus-host Interactions
10%
Yellow Fever
7%
